Literature DB >> 16084316

Mixed connective tissue disease: still crazy after all these years.

Josephine Swanton1, David Isenberg.   

Abstract

Mixed connective tissue disease (MCTD) remains a controversial diagnosis. The classification criteria have changed significantly from the original description by Sharp and colleagues in 1972 after follow-up of the original and other MCTD patients. In this article we review the clinical, serologic, and genetic studies of MCTD published in the last 10 years and ask if this term is appropriate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084316     DOI: 10.1016/j.rdc.2005.04.009

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  10 in total

Review 1.  Pediatric Mixed Connective Tissue Disease.

Authors:  Roberta A Berard; Ronald M Laxer
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

Review 2.  Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Authors:  Guillermo Barturen; Lorenzo Beretta; Ricard Cervera; Ronald Van Vollenhoven; Marta E Alarcón-Riquelme
Journal:  Nat Rev Rheumatol       Date:  2018-01-24       Impact factor: 20.543

3.  Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.

Authors:  A Mesa; J A Somarelli; W Wu; L Martinez; M B Blom; E L Greidinger; R J Herrera
Journal:  Lupus       Date:  2013-11       Impact factor: 2.911

4.  Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.

Authors:  Silje Reiseter; Øyvind Molberg; Ragnar Gunnarsson; May Brit Lund; Trond Mogens Aalokken; Pål Aukrust; Thor Ueland; Torhild Garen; Cathrine Brunborg; Annika Michelsen; Aurelija Abraityte; Anna-Maria Hoffmann-Vold
Journal:  Arthritis Res Ther       Date:  2015-08-28       Impact factor: 5.156

Review 5.  U1-RNP and TLR receptors in the pathogenesis of mixed connective tissue diseasePart I. The U1-RNP complex and its biological significance in the pathogenesis of mixed connective tissue disease.

Authors:  Agnieszka Paradowska-Gorycka
Journal:  Reumatologia       Date:  2015-05-18

6.  Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry.

Authors:  Natalia Mena-Vázquez; Antonio Fernández-Nebro; José María Pego-Reigosa; María Galindo; Ana Melissa-Anzola; Esther Uriarte-Isacelay; Alejandro Olivé-Marqués; Elena Aurrecoechea; Mercedes Freire; Eva Tomero; María Jesús García-Villanueva; Claudia Stoye; Esteban Salas-Heredia; Jose Antonio Bernal-Vidal; Eva Salgado; Ricardo Blanco; Francisco Javier Novoa; Mónica Ibáñez-Barcelo; Vicente Torrente-Segarra; Javier Narvaez; Joan Calvet; Clara Moriano Morales; Tomas Ramon Vazquez-Rodriguez; Paloma Garcia de la Peña; Cristina Bohórquez; José Luis Andreu-Sánchez; Tatiana Cobo-Ibañez; Gema Bonilla; Nuria Lozano-Rivas; Carlos Montilla; Francisco Javier Toyos; Jose Luis Marenco De la Fuente; Lorena Expósito; María Esther Ruiz-Lucea; Elia Vals; Javier Manero-Ruiz; Jose A Bernal-Vidal; Iñigo Rua-Figueroa
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580

Review 7.  "Mixed connective tissue disease": a condition in search of an identity.

Authors:  Marta R Alves; David A Isenberg
Journal:  Clin Exp Med       Date:  2020-03-04       Impact factor: 3.984

8.  Predisposition of HLA-DRB1*04:01/*15 heterozygous genotypes to Japanese mixed connective tissue disease.

Authors:  Shomi Oka; Takashi Higuchi; Hiroshi Furukawa; Kota Shimada; Atsushi Hashimoto; Akiko Komiya; Toshihiro Matsui; Naoshi Fukui; Eiichi Suematsu; Shigeru Ohno; Hajime Kono; Masao Katayama; Shouhei Nagaoka; Kiyoshi Migita; Shigeto Tohma
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

9.  The enigma of mixed connective tissue disease-challenges in routine care.

Authors:  Adrian Wanzenried; Alexandru Garaiman; Suzana Jordan; Oliver Distler; Britta Maurer
Journal:  Clin Rheumatol       Date:  2022-07-29       Impact factor: 3.650

Review 10.  Humoral Epitope Spreading in Autoimmune Bullous Diseases.

Authors:  Dario Didona; Giovanni Di Zenzo
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.